Why treatment starts at 2.5 mg

The licensed schedule starts tirzepatide at 2.5 mg weekly and moves to 5 mg after four weeks. A low start helps you tolerate the medicine while you learn how it affects you. The recommended adult maintenance strengths are 5, 10 and 15 mg, so 2.5 mg has a different job.

Some people notice appetite changes in the first days or weeks. Others notice nothing. Neither pattern predicts how the rest of treatment goes. Nobody can promise you a set weight loss in the first month. Equally, 2.5 mg can have a real effect on the body. Early experiences vary widely.

What to learn during the first four doses

Learn the injection technique from the instructions supplied with your KwikPen. Check the strength matches your prescription, learn how to prime the pen and know where the used needle goes. Get a sharps bin before your first injection so you are not improvising afterwards.

Write down the date you first use each pen, your injection dates and any symptoms that get in the way of normal eating or drinking. Your follow-up appointment goes better with notes than with memory. Include missed doses and any changes to your other medicines.

Realistic expectations for food and weight

Appetite changes are often subtle. You may feel full sooner and still enjoy food. Going all day without eating is not the goal. You still need regular meals, fluids and a routine you will keep up, even when your hunger signals feel different.

Early changes on the scales include shifts in water and bowel contents, and one weigh-in goes up or down. Compare readings taken in similar conditions over several weeks. A dramatic first week sets no pace you must keep up. A quiet first week does not mean treatment has failed.

Prepare for your first review

Before your next prescription, discuss whether you can manage normal food and enough fluids, whether symptoms are easing and whether the planned next step still suits you. Do not increase early. Do not repeat an injection after a dose you are unsure about. Do not get a stronger pen on your own to speed things up.

If you take the contraceptive pill, use a barrier method as well, or switch to a suitable non-oral method, for four weeks after starting and again for four weeks after each increase. If you use insulin or a sulphonylurea, ask your diabetes clinician for a glucose and medication plan.

When the first month needs medical attention

Get immediate assessment for severe, persistent abdominal pain, especially if the pain spreads to your back, because this can signal pancreatitis. Do not take further doses while you wait for that assessment. Repeated vomiting, being unable to keep fluids down or passing much less urine also need prompt advice.

Your next prescription is a clinical decision. Report a long break in treatment, an unexpected illness or significant side effects, even if an automated ordering system still offers the usual next strength. A safe start means knowing the planned schedule and also knowing how to pause and ask questions.

Sources

Your own medicine leaflet and prescriber come first. A source from another country does not mean the same rule applies in the UK.

  1. Mounjaro UK Summary of Product Characteristics, updated September 2026 medicines.org.uk
  2. Mounjaro UK patient information leaflet medicines.org.uk
  3. NICE: prescribing, reviewing and stopping tirzepatide nice.org.uk
  4. MHRA: GLP-1 medicines, what you need to know gov.uk

Spotted something out of date? Report a mistake.